Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1986 Nov;70(11):797–803. doi: 10.1136/bjo.70.11.797

Ophthalmic survey of a diabetic clinic. I: Ocular findings.

R H Grey, N Malcolm, D O'Reilly, A Morris
PMCID: PMC1040831  PMID: 3790479

Abstract

A medical diabetic clinic was examined for evidence of diabetic eye disease. Of 681 patients invited for ocular examination 96.6% attended for screening. The results for insulin dependent diabetics (IDDs) and non-insulin dependent diabetics (NIDDs) were analysed separately and the major findings were: Cataracts were present in 40.8% of IDDs and 46.2% of NIDDs, with an increased incidence with advancing age. For younger age groups there were significantly more cataracts in IDDs than in NIDDs (p less than 0.001). Cataract extraction was required in 4.2% of the patients, which is higher than the general population. The presence of retinopathy was related to the duration of diabetes (p less than 0.001) but not to age of onset of diabetes. Retinopathy was found in 43.4% of IDDs and 20.1% of NIDDs. Sight threatening retinopathy was present in 13.3% of IDD and 4.3% of NIDD eyes. Advanced diabetic eye disease was seen in 0.6% of eyes.

Full text

PDF
797

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaberg T. M. Clinical results in vitrectomy for diabetic traction retinal detachment. Am J Ophthalmol. 1979 Aug;88(2):246–253. doi: 10.1016/0002-9394(79)90473-2. [DOI] [PubMed] [Google Scholar]
  2. Burditt A. F., Caird F. I. Natural history of lens opacities in diabetics. Br J Ophthalmol. 1968 Jun;52(6):433–440. doi: 10.1136/bjo.52.6.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burditt A. G., Caird F. I., Draper G. J. The natural history of diabetic retinopathy. Q J Med. 1968 Apr;37(146):303–317. [PubMed] [Google Scholar]
  4. CAIRD F. I., HUTCHINSON M., PIRIE A. CATARACT AND DIABETES. Br Med J. 1964 Sep 12;2(5410):665–668. doi: 10.1136/bmj.2.5410.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CAIRD F. I., HUTCHINSON M., PIRIE A. CATARACT EXTRACTION IN AN ENGLISH POPULATION. Br J Prev Soc Med. 1965 Apr;19:80–84. doi: 10.1136/jech.19.2.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheng H. Response of proliferative diabetic retinopathy to xenon-arc photocoagulation. A multicentre randomized controlled trial. Second interim report. Trans Ophthalmol Soc U K. 1976 Jul;96(2):224–227. [PubMed] [Google Scholar]
  7. Constable I. J., Knuiman M. W., Welborn T. A., Cooper R. L., Stanton K. M., McCann V. J., Grose G. C. Assessing the risk of diabetic retinopathy. Am J Ophthalmol. 1984 Jan;97(1):53–61. doi: 10.1016/0002-9394(84)90446-x. [DOI] [PubMed] [Google Scholar]
  8. Grey R. H., Morris A. Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy. Br J Ophthalmol. 1986 Nov;70(11):804–807. doi: 10.1136/bjo.70.11.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamilton A. M. Diabetic blindness and its prevention by photocoagulation. Trans Ophthalmol Soc U K. 1978;98(2):296–298. [PubMed] [Google Scholar]
  10. Hamilton A. M., Townsend C., Khoury D., Gould E., Blach R. K. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity. Trans Ophthalmol Soc U K. 1981;101(1):87–92. [PubMed] [Google Scholar]
  11. Hercules B. L., Gayed I. I., Lucas S. B., Jeacock J. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Br J Ophthalmol. 1977 Sep;61(9):555–563. doi: 10.1136/bjo.61.9.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hockaday T. D. Diabetic maculopathy. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):915–916. doi: 10.1136/bmj.286.6369.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kahn H. A., Bradley R. F. Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes. Br J Ophthalmol. 1975 Jul;59(7):345–349. doi: 10.1136/bjo.59.7.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McGuinness R. Association of diabetes and cataract. Br Med J. 1967 May 13;2(5549):416–418. doi: 10.1136/bmj.2.5549.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Michels R. G. Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol. 1978 Feb;96(2):237–246. doi: 10.1001/archopht.1978.03910050105001. [DOI] [PubMed] [Google Scholar]
  16. Mitchell P. The prevalence of diabetic retinopathy: a study of 1300 diabetics from Newcastle and the Hunter Valley. Aust J Ophthalmol. 1980 Aug;8(3):241–246. doi: 10.1111/j.1442-9071.1980.tb00347.x. [DOI] [PubMed] [Google Scholar]
  17. Palmberg P., Smith M., Waltman S., Krupin T., Singer P., Burgess D., Wendtlant T., Achtenberg J., Cryer P., Santiago J. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology. 1981 Jul;88(7):613–618. doi: 10.1016/s0161-6420(81)34975-6. [DOI] [PubMed] [Google Scholar]
  18. Plumb A. P., Swan A. V., Chignell A. H., Shilling J. S. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol. 1982 Apr;66(4):213–218. doi: 10.1136/bjo.66.4.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reeser F., Fleischman J., Williams G. A., Goldman A. Efficacy of argon laser photocoagulation in the treatment of circinate diabetic retinopathy. Am J Ophthalmol. 1981 Dec;92(6):762–767. doi: 10.1016/s0002-9394(14)75626-0. [DOI] [PubMed] [Google Scholar]
  20. Schanzlin D. J., Jay W. H., Fritz K. J., Tripathi R. C., Gonen B. Hemoglobin A1 and diabetic retinopathy. Am J Ophthalmol. 1979 Dec;88(6):1032–1038. doi: 10.1016/0002-9394(79)90412-4. [DOI] [PubMed] [Google Scholar]
  21. Scobie I. N., MacCuish A. C., Barrie T., Green F. D., Foulds W. S. Serious retinopathy in a diabetic clinic: prevalence and therapeutic implications. Lancet. 1981 Sep 5;2(8245):520–521. doi: 10.1016/s0140-6736(81)90898-9. [DOI] [PubMed] [Google Scholar]
  22. Segal P., Treister G., Yalon M., Sandak R., Berezin M., Modan M. The prevalence of diabetic retinopathy: effect of sex, age, duration of disease and mode of therapy. Diabetes Care. 1983 Mar-Apr;6(2):149–151. doi: 10.2337/diacare.6.2.149. [DOI] [PubMed] [Google Scholar]
  23. Shea M. Early vitrectomy in proliferative diabetic retinopathy. Arch Ophthalmol. 1983 Aug;101(8):1204–1205. doi: 10.1001/archopht.1983.01040020206006. [DOI] [PubMed] [Google Scholar]
  24. Townsend C., Bailey J., Kohner E. M. Xenon arc photocoagulation in the treatment of diabetic maculopathy. Trans Ophthalmol Soc U K. 1979 Apr;99(1):13–16. [PubMed] [Google Scholar]
  25. Townsend C., Bailey J., Kohner E. Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study. Br J Ophthalmol. 1980 Jun;64(6):385–391. doi: 10.1136/bjo.64.6.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. West K. M., Erdreich L. J., Stober J. A. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980 Jul;29(7):501–508. doi: 10.2337/diab.29.7.501. [DOI] [PubMed] [Google Scholar]
  27. Yassur Y., Pickle L. W., Fine S. L., Singerman L., Orth D. H., Patz A. Optic disc neovascularisation in diabetic retinopathy: II. Natural history and results of photocoagulation treatment. Br J Ophthalmol. 1980 Feb;64(2):77–86. doi: 10.1136/bjo.64.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES